
- Oncology NEWS International Vol 10 No 10
- Volume 10
- Issue 10
Studies Seek to Find Female Biologic Factors That Affect HIV
BETHESDA, Maryland-A 5-year, $17.5-million program will investigate how HIV infection affects adolescent and adult women. Three research centers will house the Women’s HIV Pathogenesis Program, funded by the National Institute of Child Health and Human Development (NICHD). Researchers at the centers will collaborate with others in an effort to identify biologic factors unique to women that affect HIV.
BETHESDA, MarylandA 5-year, $17.5-million program will investigate how HIV infection affects adolescent and adult women. Three research centers will house the Women’s HIV Pathogenesis Program, funded by the National Institute of Child Health and Human Development (NICHD). Researchers at the centers will collaborate with others in an effort to identify biologic factors unique to women that affect HIV.
The centers will be located at the University of Washington in Seattle, the Gladstone Institute of Virology in San Francisco, and Rush-Presbyterian-St. Luke’s Medical Center in Chicago.
Researchers will focus on various subpopulations, including minority women, lesbians, female substance abusers, and women approaching or experiencing menopause. Understanding biologic factors unique to women could provide insights into how they become infected with the virus and transmit it to others, how the disease progresses in women after infection takes place, and how the disease affects women differently from men, NICHD said.
Articles in this issue
about 24 years ago
High-Dose IL-2 Is Standard in Advanced Renal Cell Cancerabout 24 years ago
RIT Safe, Effective in Elderly and Poor-Prognosis Patientsabout 24 years ago
FDA Approves Xeloda/Taxotere Combination for Advanced Breast Cancerabout 24 years ago
ODAC Recommends Approval of Radiolabeled Zevalinabout 24 years ago
Proteomics Moves From the Laboratory to Clinical Researchabout 24 years ago
Radiotherapy Not Needed in Older Lumpectomy Patients With Early Cancerabout 24 years ago
Raltitrexed + Oxaliplatin for Advanced Colorectal Cancerabout 24 years ago
Mental Fatigue Worries Chemotherapy Patientsabout 24 years ago
Patients Urged to Work With Professionals Against Fatigueabout 24 years ago
NCI Director Resigns to Head New Scientific InstituteNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.